National Institute of Aging Awards Phase II Clinical Trial Funding for Neurosom Electric Sleep Therapy in Seniors with Mild Cognitive Impairment
Neurosom’s research partner, the Brain Electrophysiology Lab (BEL), has received $2.2 million in Phase II funding from the National Institutes of Aging to conduct an FDA-monitored clinical trial to determine if Neurosom’s Electric Sleep Therapy can improve deep sleep and memory consolidation in seniors with Mild Cognitive Impairment (MCI). In the Phase I feasibility study, […]
